Skip to main content

Advertisement

Jaranol alleviates cognitive impairment in db/db mice through the PI3K/AKT pathway

  • Research
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

The widely used Radix Astragali (RA) has significant therapeutic effects on cognitive impairment (CI) caused by type 2 diabetes (T2DM). However, the effective active ingredients and the precise mechanism underly RA alleviation of T2DM-induced CI still require further study. In this study, we aim to elucidate whether and how jaranol, a key effective active ingredient in RA, influences CI in db/db mice. We used various online databases and Cytoscape to screen jaranol as the most active ingredient of RA in the treatment of T2DM-induced CI. The fear conditioning experiment, new object recognition (NOR) test, and Morris water maze (MWM) test were conducted to assess the improvement effect of jaranol on CI in diabetic mice. The protein-protein interaction (PPI) network, Cytoscape, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to identify key genes. The levels of AKT and caspase-3 were determined by Western blotting. The number of surviving hippocampal neurons was verified through Nissl staining. AutoDock was utilized for predicting potential binding sites between jaranol and key genes.As a result, jaranol attenuated CI in db/db mice probably through activation of PI3K-AKT signaling pathway by inhibiting cell apoptosis in hippocampus. Furthermore, A329 near the active site of AKT1 had hydrogen bond with jaranol. In conclusion, we suggest that jaranol may have therapeutic applications in T2DM-induced CI by targeting the PI3K-AKT signaling pathway directly via key sites. Our study provides alternative drugs and potential therapeutic targets for the prevention and treatment of T2DM-induced CI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

No datasets were generated or analysed during the current study.

References

Download references

Acknowledgements

We are grateful to all the staff in the Public Experimental Research Center and Experimental Animal Center of Xuzhou Medical University for their support and help during the experiments.

Funding

This work was supported by grants from the National Natural Science Foundation of China, Grant/Award Number: 82271205; The Jiangsu Province graduate student innovation project, Grant/Award Number: KYCX23-2925.

Author information

Authors and Affiliations

Authors

Contributions

Ye Qian, Yue Xu, Qiuyu Zhang, and Changjiang Ying conceived and designed the study. Ye Qian, Yue Xu, Qiuyu Zhang, and Chengyu Huang performed the bioinformatics analysis and data processing. Hui Li, Lin Gao, Shidi Wu, and Chengyu Qi analyzed the data and prepared figures. Ye Qian wrote the first draft of the manuscript. Ye Qian and Changjiang Ying revised the final version of the manuscript. Xiaoyan Zhou, Xiangru Wen, and Changjiang Ying supervised the entire study. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xiangru Wen, Xiaoyan Zhou or Changjiang Ying.

Ethics declarations

Ethics statement

Animal experimental procedures were carried out in accordance with the guidelines described in the 2011 revised Regulations on the Administration of Laboratory Animal Affairs in China and approved by the Institutional Animal Care and Use Committee of Xuzhou Medical University (protocol: 202207S074).

Competing interests

The authors declared no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qian, Y., Xu, Y., Zhang, Q. et al. Jaranol alleviates cognitive impairment in db/db mice through the PI3K/AKT pathway. Metab Brain Dis 40, 88 (2025). https://doi.org/10.1007/s11011-024-01527-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11011-024-01527-0

Keywords